• Simplicity, Versatility, Targeted Delivery
  • We offer a versatile catheter system for use with both standard and developing therapeutic agents.
  • RenovoRx was honored at TiEcon on May 18th, 2013 as one of the only three winning startups in the Life Sciences vertical.

About RenovoRX

RenovoRx is a medical device company headquartered in Silicon Valley, California.

We are developing solutions for targeted delivery of therapeutic and diagnostic agents

to selected sites in the peripheral vascular system.

RenovoCath™ Catheter System

We do catheters differently. This video shows the RenovoCath RC120 special features and the role these features play in delivering therapeutic agents to targeted regions.

Read More!

In the News

view all
  • RenovoCath™ RC120 Receives FDA 510(k) Clearance

    Menlo Park, CA (October 30, 2014) – RenovoRx, a leading developer of innovative solutions for targeted delivery of fluids to selected sites in the vascular system, today announced the company has received FDA 510(k) clearance of its flagship product, the … Continue reading

    Read More
  • RenovoRx Patent Issued

    Menlo Park, CA (October 28, 2014) – RenovoRx, a leading developer of innovative solutions for the isolation of blood flow and delivery of fluids to selected sites in the vascular system, today announced that the United States Patent and Trademark … Continue reading

    Read More
  • RenovoRx Board Names Shaun R. Bagai as CEO

    RenovoRx Inc. today announces that its Board of Directors has appointed Shaun R. Bagai as Chief Executive Officer and member of the Board of Directors effective June 16, 2014.

    Read More

Balloon Placement

Optimized design for targeted balloon placement

Contact Delivery

Contact delivery of therapeutic agents